https://touchoncology.com/gynecologic-cancers/conference-hub/domenica-lorusso-asco-2022-trabectedin/
Domenica Lorusso, ASCO 2022: Trabectedin for the treatment of recurrent ovarian, primary...
The phase 3 MITO23 trial investigated trabectedin (ET-743) single agent versus clinician’s choice chemotherapy in recurrent ovarian, primary peritoneal, or
for thedomenicalorussoascotrabectedin
https://mediately.co/cz/drugs/DK1tziWGxbQMToOcDeP6DecYS0M/trabectedin-ever-pharma-0-25mg-prasek-pro-koncentrat-pro-infuzni-roztok
TRABECTEDIN EVER PHARMA 0,25MG: SPC, Složení, Cena - Mediately
TRABECTEDIN EVER PHARMA 0,25MG Prášek pro koncentrát pro infuzní roztok (trabektedin (trabectedinum)): dávkování, interakce a SPC — ověřte si v databázi léků...
trabectedineverpharmaspccena
https://cureasps.org/forum/viewtopic.php?p=1002&sid=665986bf8058e8ac485a72f086a3c94f
Trabectedin (Yondelis) - Cure Alveolar Soft Part Sarcoma International (iCureASPS)
trabectedinyondeliscurealveolarsoft